The glucagon gene and its products

	Glucagon physiology, pathophysiology and prospects of glucagon antagonists for the treatment of diabetes
	GLP-1 receptor agonists for the treatment of diabetes
	GLP-2: from discovery to clinical application

Clinical reviews

	Vascular sGC activity is preserved in type 2 diabetic patients
	Retinopathy and blood pressure in type 2 diabetes
	Insulin sensitivity and adipose tissue hexosamine levels in humans
	Retinal neural impairment in diabetes
	Hepatic dysfunction and prediction of type 2 diabetes
	Adiponectin predicts type 2 diabetes: the ARIC study
	Risks associated with GDM
	Pharmacogenetics applied to the management of neonatal diabetes
	No hypoglycemia after GLP-1
	Long-term effectiveness of experiential patient education